What was the overall market valuation of the Germany fertility drug-surgery market in 2024?

The overall market valuation was $157.81 Million in 2024. Read More

What is the projected market valuation for the Germany fertility drug-surgery market by 2035?

The projected valuation for 2035 is $290.0 Million. Read More

What is the expected CAGR for the Germany fertility drug-surgery market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 5.69%. Read More

Which companies are considered key players in the Germany fertility drug-surgery market?

Key players include Merck KGaA, Ferring Pharmaceuticals, Bayer AG, AbbVie Inc., Eli Lilly and Company, SAGE Therapeutics, HRA Pharma, and Irvine Scientific. Read More

What are the estimated market values for male and female underlying causes in the Germany fertility drug-surgery market?

The estimated market values for male and female underlying causes range from $70.0 Million to $130.0 Million and $87.81 Million to $160.0 Million, respectively. Read More

What are the market values for various fertility drugs in the Germany market?

Market values for fertility drugs include Clomiphene Citrate at $20.0 Million to $40.0 Million and Gonadotrophins at $30.0 Million to $60.0 Million. Read More

What surgical procedures are included in the Germany fertility drug-surgery market, and what are their estimated values?

Surgical procedures include Hysteroscopy valued at $20.0 Million to $40.0 Million and Laparoscopy and Robotic Laparoscopy valued at $30.0 Million to $60.0 Million. Read More

What are the estimated market values for different end-users in the Germany fertility drug-surgery market?

Estimated market values for end-users include Hospitals at $50.0 Million to $100.0 Million and Fertility Clinics at $30.0 Million to $55.0 Million. Read More

How does the market for fertility drugs compare to the market for surgical procedures in Germany?

The market for fertility drugs appears to have a broader range, with values reaching up to $80.0 Million for 'Others', compared to surgical procedures which peak at $60.0 Million. Read More

What trends are anticipated in the Germany fertility drug-surgery market as it approaches 2035?

Trends suggest a steady growth trajectory, with increasing investments from key players and a rising demand for advanced fertility treatments. Read More

Germany Fertility Drug Surgery Market

ID: MRFR/Pharma/52248-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

Germany Fertility Drug Surgery Market Research Report By Underlying Cause (Male, Female), By Drugs (Clomiphene Citrate, Letrozole), By Procedures (Hysteroscopy, Laparoscopy, Robotic Laparoscopy) and By End User (Fertility Clinics) -Forecast to 2035

Germany Fertility Drug Surgery Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Underlying Cause (USD Million)
  1. 4.1.1 Male
  2. 4.1.2 Female
2. 4.2 Food, Beverages & Nutrition, BY Drug (USD Million)
  1. 4.2.1 Clomiphene Citrate
  2. 4.2.2 Letrozole
  3. 4.2.3 Serophene
  4. 4.2.4 Hormone Treatment
  5. 4.2.5 Gonadotrophins
  6. 4.2.6 Aromatase Inhibitors
  7. 4.2.7 Estrogen Receptor Modulators
  8. 4.2.8 Dopamine Agonists
  9. 4.2.9 Metformin Hydrochloride
  10. 4.2.10 Others
3. 4.3 Food, Beverages & Nutrition, BY Procedures (USD Million)
  1. 4.3.1 Hysteroscopy
  2. 4.3.2 Laparoscopy and Robotic Laparoscopy
  3. 4.3.3 Laparotomy/Open Surgery
  4. 4.3.4 Egg Retrieval
  5. 4.3.5 Varicocelectomy
  6. 4.3.6 Vasectomy Reversal
  7. 4.3.7 Sperm Retrieval
4. 4.4 Food, Beverages & Nutrition, BY End-User (USD Million)
  1. 4.4.1 Fertility Clinics
  2. 4.4.2 Hospitals
  3. 4.4.3 Clinical Research Institutes
  4. 4.4.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Merck KGaA (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Ferring Pharmaceuticals (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 AbbVie Inc. (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Eli Lilly and Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 SAGE Therapeutics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 HRA Pharma (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Irvine Scientific (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GERMANY MARKET ANALYSIS BY UNDERLYING CAUSE
3. 6.3 GERMANY MARKET ANALYSIS BY DRUG
4. 6.4 GERMANY MARKET ANALYSIS BY PROCEDURES
5. 6.5 GERMANY MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY UNDERLYING CAUSE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY UNDERLYING CAUSE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY DRUG, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY DRUG, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY PROCEDURES, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY PROCEDURES, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY UNDERLYING CAUSE, 2025-2035 (USD Million)
  2. 7.2.2 BY DRUG, 2025-2035 (USD Million)
  3. 7.2.3 BY PROCEDURES, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Underlying Cause (USD Million, 2025-2035)

Male
Female

Food, Beverages & Nutrition By Drug (USD Million, 2025-2035)

Clomiphene Citrate
Letrozole
Serophene
Hormone Treatment
Gonadotrophins
Aromatase Inhibitors
Estrogen Receptor Modulators
Dopamine Agonists
Metformin Hydrochloride
Others

Food, Beverages & Nutrition By Procedures (USD Million, 2025-2035)

Hysteroscopy
Laparoscopy and Robotic Laparoscopy
Laparotomy/Open Surgery
Egg Retrieval
Varicocelectomy
Vasectomy Reversal
Sperm Retrieval

Food, Beverages & Nutrition By End-User (USD Million, 2025-2035)

Fertility Clinics
Hospitals
Clinical Research Institutes
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”